皇家华人

header-logo
GettyImages-609179959-hero
Medicine
Joan Neuner, MD

Joan Neuner, MD, MPH

Professor, Medicine (General Internal Medicine)

Education

MD, University of Wisconsin Medical School, Madison
Residency in Primary Cary and Internal Medicine, Harvard Medical School, Boston, MA
Chief Resident in Primary Care & Internal Medicine Harvard Medical School, Boston, MA 鈥�97-鈥�98
Fellowship in General Internal Medicine Harvard Medical School, Boston, MA
MPH, Harvard School of Public Health, Boston, MA
View physician profile

Biography

Dr. Neuner is a board-certified physician specializing in internal medicine with a practice at the 皇家华人. She also sees osteoporosis patients in the multidisciplinary MCW Osteoporosis and Bone Mineral Disorders Clinic. Her current roles include: Georgia Carroll Professor of Women’s Health, Department of Medicine; MCW Cancer Prevention and Outcomes Program leader; and Center for Advancing Population Sciences Population Health Unit Leader. Dr. Neuner’s research is aimed at advancing equitable health delivery and improving decision-making in women’s health, particularly around medication use.

Publications

  • (Neuner JM, Stolley M, Kamaraju S, Tiegs J, Sparapani R, Makris V, Flynn KE.) Breast Cancer Res Treat. 2024 Nov 26 PMID: 39592520 SCOPUS ID: 2-s2.0-85210370572 11/27/2024

  • (Luebke MC, Neuner JM, Balza J, Davidson ERW, Hokanson JA, Marowski S, Corey O'Connor R, Schmitt E, Winn AN, Flynn KE.) Fam Pract. 2024 Oct 08;41(5):798-806 PMID: 39026426 PMCID: PMC11461143 SCOPUS ID: 2-s2.0-85206018320 07/19/2024

  • (Neuner J, Schmitt E, Winn A, Davidson E, O'Connor RC, Marowski S, Luebke M, Balza J, Attewell M, Flynn KE.) Urogynecology (Phila). 2024 Jun 21 PMID: 38954604 07/02/2024

  • (Luebke MC, Davidson ERW, Crotty BH, Fergestrom N, O'Connor RC, Schmitt E, Winn AN, Flynn KE, Neuner JM.) Urogynecology (Phila). 2024 May 01;30(5):489-497 PMID: 37881958 PMCID: PMC11002977 SCOPUS ID: 2-s2.0-85191898273 10/26/2023

  • (Lee AY, Lyons AT, Makris V, Kamaraju S, Stolley MR, Neuner JM, Flynn KE.) Support Care Cancer. 2024 Apr 02;32(4):265 PMID: 38565669 SCOPUS ID: 2-s2.0-85189209769 04/03/2024

  • (Cortina CS, Siegel EL, Polovneff A, Sahyouni G, Neuner JM, Petroll AE, Stolley M.) Ann Surg Oncol. 2023 Nov;30(12):6978-6980 PMID: 37620531 PMCID: PMC10591886 SCOPUS ID: 2-s2.0-85168660167 08/25/2023

  • (Patel UJ, Moureau MK, Neuner JM, Brown HW.) OBM Geriat. 2023;7(4) PMID: 38567050 PMCID: PMC10986360 01/01/2023

  • (Neuner JM, Fergestrom N, Pezzin LE, Laud PW, Ruddy KJ, Winn AN.) Breast Cancer Res Treat. 2023 Jan;197(1):223-233 PMID: 36357711 SCOPUS ID: 2-s2.0-85141681578 11/11/2022

  • (Wu RR, Myers RA, Neuner J, McCarty C, Haller IV, Harry M, Fulda KG, Dimmock D, Rakhra-Burris T, Buchanan A, Ginsburg GS, Orlando LA.) BMC Health Serv Res. 2022 Dec 06;22(1):1486 PMID: 36474257 PMCID: PMC9727967 SCOPUS ID: 2-s2.0-85143378801 12/07/2022

  • (Wu RR, Myers RA, Neuner J, McCarty C, Haller IV, Harry M, Fulda KG, Dimmock D, Rakhra-Burris T, Buchanan A, Ginsburg GS, Orlando LA.) BMC Health Services Research. December 2022;22(1) SCOPUS ID: 2-s2.0-85143378801 12/01/2022

  • (Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE.) J Am Pharm Assoc (2003). 2022;62(4):1321-1328.e3 PMID: 35393248 SCOPUS ID: 2-s2.0-85127492109 04/09/2022

  • (Neuner JM, Zhou Y, Fergestrom N, Winn A, Pezzin L, Laud PW, Beyer K.) J Am Pharm Assoc (2003). 2021;61(6):e25-e31 PMID: 34340925 PMCID: PMC8783974 SCOPUS ID: 2-s2.0-85115339368 08/04/2021

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.